Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized tRial Employing topiCal roflumilasT Foam to Treat Scalp Psoriasis (ARRECTOR)

NCT05028582 is registered in ClinicalTrials.gov with Arcutis Biotherapeutics, Inc. as lead sponsor.

NCT NCT05028582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05028582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized tRial Employing topiCal roflumilasT Foam to Treat Scalp Psoriasis (ARRECTOR)
Lead sponsor
Arcutis Biotherapeutics, Inc.
Phase
Phase 3
Overall status
Completed
Start date
August 24, 2021
Completion date
June 3, 2022
Enrollment
432 (actual)
Sites
49

Conditions

As the registry lists them; a condition with its own page is linked.

scalp psoriasis